SEELOS THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Seelos Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Seelos Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $1.71M.
  • Seelos Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $4.09M.
  • Seelos Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$37.9M, a 48.5% increase from 2022.
  • Seelos Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$73.5M, a 11.3% decline from 2021.
  • Seelos Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$66M, a 246% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.09M $1.71M +$31.2M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$27.1M -$2.66M +$10.8M +80.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$37.9M -$5.45M +$13.2M +70.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 -$51.1M $10.5M +$30.1M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$81.2M -$29.5M -$8.22M -38.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$73M -$13.4M +$570K +4.07% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$73.5M -$18.7M +$8.6M +31.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 -$82.1M -$19.6M -$8.79M -81.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$73.3M -$21.3M -$12.4M -140% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$60.9M -$14M +$5.12M +26.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$66M -$27.3M -$20.8M -323% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 -$45.2M -$10.8M -$6.73M -164% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$38.5M -$8.86M -$5.13M -138% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$33.4M -$19.1M -$14.3M -296% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$19.1M -$6.45M +$4.21M +39.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-04
Q3 2020 -$23.3M -$4.09M -$869K -27% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$22.4M -$3.73M -$1.87M -100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$20.6M -$4.83M +$30.7M +86.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 -$51.3M -$10.7M -$9.44M -774% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$41.8M -$3.22M -$2.12M -194% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$39.7M -$1.86M -$1.37M -275% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$38.3M -$35.5M -$34.9M -5272% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$3.48M -$1.22M +$1.23M +50.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 -$4.7M -$1.1M +$2.74M +71.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$7.44M -$497K +$977K +66.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$8.41M -$661K -$8.73M -108% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-21
Q4 2017 $321K -$2.45M -$2.15M -718% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 $2.47M -$3.83M -$2.54M -197% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $5.01M -$1.47M +$1.86M +55.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $3.15M $8.07M +$10.6M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$7.43M -$299K +$2.03M +87.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$9.47M -$1.29M +$3.74M +74.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$13.2M -$3.34M +$1.91M +36.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$15.1M -$2.51M +$3.91M +60.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$19M -$2.33M +$15M +86.5% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-09
Q3 2015 -$34M -$5.03M -$1.92M -61.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$32.1M -$5.25M -$7.12M -379% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$24.9M -$6.41M -$3.15M -96.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$21.8M -$17.3M -$15.9M -1185% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$5.84M -$3.11M -$128K -4.29% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$5.72M $1.88M +$5.81M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$11.5M -$3.26M +$5.41M +62.4% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$16.9M -$1.35M +$18.3M +93.2% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$35.2M -$2.99M -$491K -19.7% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$34.7M -$3.94M +$991K +20.1% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$35.7M -$8.67M -$3.96M -84% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$31.8M -$19.6M -$14.9M -319% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-17
Q3 2012 -$16.8M -$2.49M -$274K -12.3% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-17
Q2 2012 -$16.6M -$4.93M +$2.87M +36.8% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-17
Q1 2012 -$19.4M -$4.71M -$1.3M -38.2% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-17
Q4 2011 -$18.1M -$4.69M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$2.22M +$386K +14.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 -$7.79M -$3.52M -82.2% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 -$3.41M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 -$2.61M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$4.28M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.